Skip to Content

The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content.

Coagulation Factor IX, Human, recombinant

ATC (Anatomical Therapeutic Chemical Classification)


Therapeutic Categories

Hemostatic agent

Blood coagulation factor substitute

Foreign Names

  • Factor IX coagulationis humanus (ADNr) (Latin)
  • Blutgerinnungsfaktor IX vom Menschen, rekombinant (German)
  • Facteur de coagulation humain, recombinant (French)

Generic Names

Brand Names

  • BeneFIX
    Baxter, Spain; Baxter, Ireland; Biovitrum, Sweden; Pfizer, Switzerland; Wyeth, Austria; Wyeth, Australia; Wyeth, Belgium; Wyeth, Brazil; Wyeth, Canada; Wyeth, Chile; Wyeth, Colombia; Wyeth, Czech Republic; Wyeth, Germany; Wyeth, Denmark; Wyeth, Finland; Wyeth, France; Wyeth, Greece; Wyeth, Hungary; Wyeth, Iceland; Wyeth, Italy; Wyeth, Luxembourg; Wyeth, Netherlands; Wyeth, New Zealand; Wyeth, Sweden; Wyeth, Taiwan; Wyeth, United States; Wyeth, Venezuela; Wyeth Europa, Norway; Wyeth Pharmaceuticals, United Kingdom
  • Betafact
    Swedish Orphan, Germany


BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.